ALS Biopharma Press Release

Doylestown, PA. September 6, 2011:

ALS Biopharma is pleased to announce that it was been selected as a finalist in the Philadelphia Business Journal Life Sciences Award program, and will be recognized at an awards ceremony in Philadelphia on Oct. 7.

ALS Biopharma is being recognized as an innovative early stage biotechnology company, seeking to discover new therapies to treat the debilitating disorder of amyotrophic lateral sclerosis.

Back to Press Releases